Results 91 to 100 of about 1,784,951 (230)

Development of a novel method for detection of C. difficile using HS-SPME-GC-MS [PDF]

open access: yes, 2014
AIMS:A novel method has been developed that allows successful differentiation between Clostridium difficile culture-positive and culture-negative stool samples based on volatile organic compound (VOC) evolution and detection by headspace solid-phase ...
Dean, John   +4 more
core   +1 more source

Microbiota Signatures in Early Life and Their Association With Food Allergy: A Systematic Review

open access: yesAllergy, EarlyView.
ABSTRACT Food allergy (FA) is increasing worldwide, and early life may be a critical window for immune training. We systematically reviewed observational human studies linking early‐life microbiota (infant, maternal, environmental, or extraintestinal) profiled using culture‐based and/or culture‐independent methods (including sequencing‐based approaches)
Eduard Flores Ventura   +7 more
wiley   +1 more source

Investigation into the mobile genetic elements of Clostridium difficile [PDF]

open access: yes, 2013
Clostridium difficile is a pathogenic bacterium that can colonise both humans and various animals. Toxin production leads to clinical symptoms ranging from mild to severe diarrhoea and can result in potentially fatal pseudomembranous colitis.
Brouwer, MSM
core  

Clostridium difficile Infection, Colorado and the Northwestern United States, 2007

open access: yesEmerging Infectious Diseases, 2012
To determine the incidence of Clostridium difficile infection during 2007, we examined infection in adult inpatient and outpatient members of a managed-care organization. Incidence was 14.9 C. difficile infections per 10,000 patient-years.
Jennifer L. Kuntz   +8 more
doaj   +1 more source

The difficile in Clostridium difficile infection [PDF]

open access: yesInternational Journal of Infectious Diseases, 2018
Garabet, Akoghlanian, Seetha, Lakshmi
openaire   +2 more sources

Delayed Loop Ileostomy Reversal Increases the Risk of Colitis and Clostridium difficile Infection

open access: yesANZ Journal of Surgery, EarlyView.
Delayed loop ileostomy reversal is associated with increased post‐operative complications specifically colitis and Clostridium difficile colitis. The COVID‐19 pandemic caused a significant delay in ileostomy reversal timing. ABSTRACT Background Temporary loop ileostomy formation is a routine procedure performed to protect distal colorectal anastomosis.
Yan S. Tan   +12 more
wiley   +1 more source

Modelling the transmission of healthcare associated infections: a systematic review. [PDF]

open access: yes, 2013
BACKGROUND: Dynamic transmission models are increasingly being used to improve our understanding of the epidemiology of healthcare-associated infections (HCAI). However, there has been no recent comprehensive review of this emerging field.
Edmunds, William J   +9 more
core   +2 more sources

Dietary-based gut flora modulation against Clostridium difficile onset [PDF]

open access: yes, 2007
Clostridium difficile infection is a frequent complication of antibiotic therapy in hospitalised patients, which today is attracting more attention than ever and has led to its classification as a 'superbug'.
Tuohy, K.M.   +2 more
core   +4 more sources

In Vitro Investigation of Auranofin as a Treatment for Clostridium difficile Infection

open access: yesDrugs in R&D, 2020
Background Clostridium difficile infection is the leading cause of hospital-acquired gastrointestinal infection and incidence rates continue to rise. Clostridium difficile infection is becoming increasingly complex to treat owing to the rise in treatment
Christine Roder, Eugene Athan
doaj   +1 more source

Gut microbiota as a novel therapeutic target for eating disorders and obesity

open access: yesBritish Journal of Pharmacology, EarlyView.
The graphical abstract highlights the bidirectional interaction between the gut microbiota and central homeostatic and hedonic mechanisms regulating food intake, which contributes to overweight and obesity. It also illustrates emerging microbiota‐based biomarkers and therapeutic strategies (including prebiotics, probiotics, postbiotics, synbiotics and ...
Solveiga Samulėnaitė   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy